RT Journal Article
SR Electronic
T1 Ezetimibe plus moderate-intensity statin versus high-intensity statin
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 38
OP 38
DO 10.1136/dtb.2023.000008
VO 61
IS 3
YR 2023
UL http://dtb.bmj.com/content/61/3/38.abstract
AB Overview of: Kim BK, Hong SJ, Lee YJ, et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet. 2022;400:380–390